Xcout Intel
GlycanAge
GlycanAge is a biotechnology firm headquartered in Newcastle upon Tyne, United Kingdom, that develops science-backed biological age testing products measuring IgG glycans to assess chronic inflammation and lifestyle impacts.
Subscribe to see GlycanAge’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GlycanAge at a glance
GlycanAge is a healthcare company headquartered in United Kingdom. Its most recent funding round, Seed, raised $4.2M in February 2024. Xcout tracks 7 named people at GlycanAge, including Zornitsa Dimitrova (Chief Operating Officer).
GlycanAge leadership
- Zornitsa DimitrovaChief Operating Officer
- Martin IlievChief Financial Officer
- Marko TarnajChief Product Officer
- Vladimira MihaylovaChief Marketing Officer
- Nikolina LaucCEO, Co-Founder
- Filip LaucCTO, Co-Founder
1 more named person on record for GlycanAge, with roles, board committees and tenure — see the full roster →
GlycanAge funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.2M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
GlycanAge competitors
A few of GlycanAge's closest competitors — see the full list of competitors and alternatives →
Inocras Inc. is a bioinformatics-led biotechnology company headquartered in San Diego, California. The firm utilizes whole genome data and proprietary artificial intelligence analytics to deliver curated genomic care.
Cyted Health delivers a diagnostic platform that combines minimally invasive cell collection with high-resolution molecular analysis. This platform is designed to detect early biological markers.
Asparia Glycomics is a biotechnology company based in San Sebastián, Spain, specializing in glycoscience, precision analytics, and glycotechnology services.
Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship offering is EpiSwitch, an exclusive technological platform employed for discovering, assessing, validating, and tracking epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These are crucial for developing medical diagnostic kits, predicting disease onset, aiding in diagnosis, and informing therapeutic strategies. The company's key products encompass the EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic tool for forecasting patient responses to checkpoint inhibitor immunotherapy; the EpiSwitch CST (Covid Severity Test), a sophisticated blood test designed to predict the severity of COVID-19 in adults; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome analysis and novel biomarker discovery. Established in 2007, Oxford BioDynamics Plc maintains its headquarters in Oxford, United Kingdom.
Infinity Bio, Inc. is a biotechnology research company that provides detailed insights into the immune system utilizing its proprietary antibody reactome profiling platform.
Nightingale Health Plc provides advanced health check and remote health check products designed for the healthcare, insurance, government, and consumer health sectors. The company also offers proprietary 'omics technology and preventive screening solutions to support medical research and disease risk detection.
Get GlycanAge's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GlycanAge in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access